Single-photon Emission Computed Tomography in Neurotherapeutics

Overview

Journal NeuroRx

Specialty Neurology

Date 2005 May 18

PMID 15897948

Citations 12

Authors

Michael D Devous Sr

Affiliations

Soon will be listed here.

Abstract

The measurement of regional cerebral blood flow (rCBF) by single-photon emission computed tomography (SPECT) is a powerful clinical and research tool. There are several clinical applications now documented, a substantial number under active investigation, and a larger number yet to be studied. Standards regarding patient imaging environment and image presentation are becoming established. This article reviews key aspects of SPECT functional brain imaging in clinical practice, with a particular emphasis on therapeutics, including 1) the quality of the tomographic device, 2) the radiopharmaceutical employed, 3) environmental conditions at the time of radiotracer administration, 4) characteristics of the subject, 5) the format used for image presentation, and 6) the essential components of image processing necessary to the achievement of high-quality SPECT brain images. Next, a brief description of relevant radiation safety issues is provided. Finally, applications in molecular imaging, especially in small animal imaging for research as well as drug discovery and development are discussed. The gamut of SPECT studies from currently routine clinical applications to molecular imaging offers a wonderful frontier for opportunities to employ functional brain imaging in neurotherapeutics.

Citing Articles

SISCOS in focal cortical dysplasia: localization and comparative analysis with MRI.

Khan D, Sagar S, Jaleel J, Umar M, Tripathi M, Tripathi M Neuroradiology. 2024; 66(11):1993-2001.

PMID: 39060800 DOI: 10.1007/s00234-024-03434-8.

Brain SPECT as a Biomarker of Neurodegeneration in Dementia in the Era of Molecular Imaging: Still a Valid Option?.

Ferrando R, Damian A Front Neurol. 2021; 12:629442.

PMID: 34040574 PMC: 8141564. DOI: 10.3389/fneur.2021.629442.

Methods to measure, model and manipulate fluid flow in brain.

Chatterjee K, Carman-Esparza C, Munson J J Neurosci Methods. 2019; 333:108541.

PMID: 31838183 PMC: 7607555. DOI: 10.1016/j.jneumeth.2019.108541.

Imaging of cerebral blood flow in patients with severe traumatic brain injury in the neurointensive care.

Rostami E, Engquist H, Enblad P Front Neurol. 2014; 5:114.

PMID: 25071702 PMC: 4083561. DOI: 10.3389/fneur.2014.00114.

Neuroimaging in epilepsy.

Roy T, Pandit A Ann Indian Acad Neurol. 2011; 14(2):78-80.

PMID: 21808467 PMC: 3141493. DOI: 10.4103/0972-2327.82787.

References

Acton P, Kung H . Small animal imaging with high resolution single photon emission tomography. Nucl Med Biol. 2003; 30(8):889-95. DOI: 10.1016/s0969-8051(03)00112-4. View

Catafau A . Brain SPECT in clinical practice. Part I: perfusion. J Nucl Med. 2001; 42(2):259-71. View

Tavitian B . In vivo imaging with oligonucleotides for diagnosis and drug development. Gut. 2003; 52 Suppl 4:iv40-7. PMC: 1867756. DOI: 10.1136/gut.52.suppl_4.iv40. View

Eckert T, Eidelberg D . Neuroimaging and therapeutics in movement disorders. NeuroRx. 2005; 2(2):361-71. PMC: 1064997. DOI: 10.1602/neurorx.2.2.361. View

Acton P, Choi S, Plossl K, Kung H . Quantification of dopamine transporters in the mouse brain using ultra-high resolution single-photon emission tomography. Eur J Nucl Med Mol Imaging. 2002; 29(5):691-8. DOI: 10.1007/s00259-002-0776-7. View

Phelps M, Kuhl D, Mazziota J . Metabolic mapping of the brain's response to visual stimulation: studies in humans. Science. 1981; 211(4489):1445-8. DOI: 10.1126/science.6970412. View

Devous Sr M, Payne J, Lowe J, Leroy R . Comparison of technetium-99m-ECD to Xenon-133 SPECT in normal controls and in patients with mild to moderate regional cerebral blood flow abnormalities. J Nucl Med. 1993; 34(5):754-61. View

Rogg J, Rutigliano M, Yonas H, Johnson D, Pentheny S, Latchaw R . The acetazolamide challenge: imaging techniques designed to evaluate cerebral blood flow reserve. AJR Am J Roentgenol. 1989; 153(3):605-12. DOI: 10.2214/ajr.153.3.605. View

Younes C, Boisgard R, Tavitian B . Labelled oligonucleotides as radiopharmaceuticals: pitfalls, problems and perspectives. Curr Pharm Des. 2002; 8(16):1451-66. DOI: 10.2174/1381612023394467. View

10.

Bakshi R, Minagar A, Jaisani Z, Wolinsky J . Imaging of multiple sclerosis: role in neurotherapeutics. NeuroRx. 2005; 2(2):277-303. PMC: 1064992. DOI: 10.1602/neurorx.2.2.277. View

11.

Pirko I, Fricke S, Johnson A, Rodriguez M, Macura S . Magnetic resonance imaging, microscopy, and spectroscopy of the central nervous system in experimental animals. NeuroRx. 2005; 2(2):250-64. PMC: 1064990. DOI: 10.1602/neurorx.2.2.250. View

12.

Lee B, Newberg A . Neuroimaging in traumatic brain imaging. NeuroRx. 2005; 2(2):372-83. PMC: 1064998. DOI: 10.1602/neurorx.2.2.372. View

13.

Paroo Z, Corey D . Imaging gene expression using oligonucleotides and peptide nucleic acids. J Cell Biochem. 2003; 90(3):437-42. DOI: 10.1002/jcb.10626. View

14.

Verhoeff N . Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders. Psychopharmacology (Berl). 2000; 147(3):217-49. DOI: 10.1007/s002130051163. View

15.

Fry R, Grosovsky A, HANAWALT P, Jostes R, Little J, Morgan W . The Impact of Biology on Risk Assessment--workshop of the National Research Council's Board on Radiation Effects Research. July 21-22, 1997, National Academy of Sciences, Washington, DC. Radiat Res. 1998; 150(6):695-705. View

16.

Heinz A, Jones D, Raedler T, Coppola R, Knable M, Weinberger D . Neuropharmacological studies with SPECT in neuropsychiatric disorders. Nucl Med Biol. 2000; 27(7):677-82. DOI: 10.1016/s0969-8051(00)00135-9. View

17.

BOND V, Wielopolski L, Shani G . Current misinterpretations of the linear no-threshold hypothesis. Health Phys. 1996; 70(6):877-82. DOI: 10.1097/00004032-199606000-00014. View

18.

Roland P, Tobey E, Devous Sr M . Preoperative functional assessment of auditory cortex in adult cochlear implant users. Laryngoscope. 2001; 111(1):77-83. DOI: 10.1097/00005537-200101000-00013. View

19.

Chatziioannou A, Cherry S, Shao Y, Silverman R, Meadors K, Farquhar T . Performance evaluation of microPET: a high-resolution lutetium oxyorthosilicate PET scanner for animal imaging. J Nucl Med. 1999; 40(7):1164-75. PMC: 3272501. View

20.

Massoud T, Gambhir S . Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 2003; 17(5):545-80. DOI: 10.1101/gad.1047403. View